A 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial of ziprasidone as monotherapy for major depressive disorder.
Papakostas, George I
A 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial of ziprasidone as monotherapy for major depressive disorder. [electronic resource] - The Journal of clinical psychiatry Dec 2012 - 1541-7 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1555-2101
10.4088/JCP.12m07670 doi
Adult
Antipsychotic Agents--adverse effects
Depressive Disorder, Major--diagnosis
Double-Blind Method
Female
Humans
Male
Middle Aged
Personality Inventory--statistics & numerical data
Piperazines--adverse effects
Psychometrics
Thiazoles--adverse effects
A 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial of ziprasidone as monotherapy for major depressive disorder. [electronic resource] - The Journal of clinical psychiatry Dec 2012 - 1541-7 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1555-2101
10.4088/JCP.12m07670 doi
Adult
Antipsychotic Agents--adverse effects
Depressive Disorder, Major--diagnosis
Double-Blind Method
Female
Humans
Male
Middle Aged
Personality Inventory--statistics & numerical data
Piperazines--adverse effects
Psychometrics
Thiazoles--adverse effects